Title |
CD20+ B Cell Depletion Alters T Cell Homing
|
---|---|
Published in |
The Journal of Immunology, May 2014
|
DOI | 10.4049/jimmunol.1303125 |
Pubmed ID | |
Authors |
Yolanda S. Kap, Nikki van Driel, Jon D. Laman, Paul P. Tak, Bert A. ’t Hart |
Abstract |
Depleting mAbs against the pan B cell marker CD20 are remarkably effective in the treatment of autoimmune-mediated inflammatory disorders, but the underlying mechanisms are poorly defined. The primary objective of this study was to find a mechanistic explanation for the remarkable clinical effect of the anti-CD20 mAbs in a representative nonhuman primate autoimmune-mediated inflammatory disorder model, experimental autoimmune encephalomyelitis (EAE) in common marmosets, allowing detailed analysis of secondary lymphoid organs (SLO). We observed that the depletion of CD20(+) B cells creates a less immunostimulatory environment in the SLO reflected by reduced expression of MHC class II, CD40, CD83, and CD80/CD86. APCs isolated from SLO of B cell-depleted EAE monkeys were also less responsive to mitogenic stimulation. The depleted B cell areas were replenished by T cells, of which the majority expressed CD127 (IL-7R) and CCR7. Such effects were not detected in EAE marmosets treated with mAb against BLyS or APRIL, where B cell depletion via withdrawal of essential survival cytokines was not associated with a marked clinical effect. We propose that at least part of the efficacy of anti-CD20 mAb therapy is attributable to the sustained CCR7 expression on T cells within SLO, limiting their release into the circulation. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 7% |
Germany | 1 | 4% |
Unknown | 24 | 89% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 26% |
Other | 6 | 22% |
Student > Ph. D. Student | 5 | 19% |
Student > Bachelor | 3 | 11% |
Student > Postgraduate | 2 | 7% |
Other | 2 | 7% |
Unknown | 2 | 7% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 7 | 26% |
Immunology and Microbiology | 6 | 22% |
Medicine and Dentistry | 6 | 22% |
Biochemistry, Genetics and Molecular Biology | 3 | 11% |
Energy | 1 | 4% |
Other | 1 | 4% |
Unknown | 3 | 11% |